|
D4S
|
Daiichi Sankyo Company Limited
|
DE
|
F
|
|
DUL
|
Alnylam Pharmaceuticals Inc
|
DE
|
F
|
|
EII
|
Eisai Co. Ltd
|
DE
|
F
|
|
GE9
|
Genmab A/S
|
DE
|
F
|
|
GE91
|
GENMAB AS SP.ADR/1/10DK 1
|
DE
|
F
|
|
I7G
|
Ipsen S.A
|
DE
|
F
|
|
I7G0
|
IPSEN SA SP.ADR 1/4/ EO 1
|
DE
|
F
|
|
ICY
|
Incyte Corporation
|
DE
|
F
|
|
IDP
|
Biogen Inc
|
DE
|
F
|
|
J7Z
|
Jazz Pharmaceuticals plc
|
DE
|
F
|
|
KY4
|
Kyowa Kirin Co. Ltd
|
DE
|
F
|
|
LGDN
|
Ligand Pharmaceuticals Incorporated
|
DE
|
F
|
|
NKB2
|
TG Therapeutics Inc
|
DE
|
F
|
|
NNFN
|
MannKind Corporation
|
DE
|
F
|
|
NOTA
|
Novartis AG
|
DE
|
F
|
|
OFK
|
Orion Oyj
|
DE
|
F
|
|
OFK0
|
ORION CORP.B UNSP.ADR 1/2
|
DE
|
F
|
|
P0F
|
EGETIS THERAPEUTICS AB
|
DE
|
F
|
|
P731
|
MEDEXUS PHARMACEUTIC.
|
DE
|
F
|
|
PHG
|
PHARMING GRP SP. ADRS
|
DE
|
F
|